Participants will receive 1 dose of JEV-I and 1 dose of MMR concurrently on Day 0, with each vaccine administered on a different side of the body, and a second dose of JEV-I 7-10 days later. Blood sampling will be performed on Day 0 and 30 days after the second dose of JEV-I.

0.5ml for each dose, manufactured by Liaoning Chengda Biotechnology CO., LTD, administered in the deltoid area of lateral arm by intramuscular injection.

Vero cell-drived inactive Japanese encephalitis vaccine

0.5ml for each dose (after dissolving), manufactured by Shanghai Institute of Biological Products CO., LTD, administered in the lower part of the deltoid area of lateral arm, by subcutaneous injection.

Measles-Mumps-Rubella Vaccine

Participants will receive 2 doses of JEV-I (7-10 days apart). Blood sampling will be performed on Day 0 and 30 days after the second dose of JEV-I.

Participants will receive 1 doses of MMR. Blood sampling will be performed on Day 0 and Day 30.

유지할 수 있습니다. Hébert J, Muccilli A, Wennberg RA, Tang-Wai DF. 자가면역성 뇌염(Autoimmune encephalitis) and Autoantibodies: A Review of Cl

질환 정보

자가면역성 뇌염의 원인, 진단, 치료 및 관리

임상시험 현황

베로세포 기반 비활성 일본뇌염 백신, 홍역-볼거리-풍진 백신